155 related articles for article (PubMed ID: 31383581)
21. ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8
Guan T; Dominguez CX; Amezquita RA; Laidlaw BJ; Cheng J; Henao-Mejia J; Williams A; Flavell RA; Lu J; Kaech SM
J Exp Med; 2018 Apr; 215(4):1153-1168. PubMed ID: 29449309
[TBL] [Abstract][Full Text] [Related]
22. Chromosome Translocation t(14;21)(q11;q22) Activates Both
Panagopoulos I; Gorunova L; Johannsdottir IMR; Andersen K; Holth A; Beiske K; Heim S
Cancer Genomics Proteomics; 2020; 17(1):41-48. PubMed ID: 31882550
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D3 deregulation by juxtaposition with IGH locus in a t(6;14)(p21;q32)-positive T-cell acute lymphoblastic leukemia.
Nguyen-Khac F; Barin C; Chapiro E; Macintyre EA; Romana S; Bernard OA
Leuk Res; 2010 Jan; 34(1):e13-4. PubMed ID: 19665788
[No Abstract] [Full Text] [Related]
24. Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia.
Cramer SD; Hixon JA; Andrews C; Porter RJ; Rodrigues GOL; Wu X; Back T; Czarra K; Michael H; Cam M; Chen J; Esposito D; Senkevitch E; Negi V; Aplan PD; Li W; Durum SK
Leukemia; 2018 Aug; 32(8):1795-1882. PubMed ID: 29535426
[No Abstract] [Full Text] [Related]
25. [Hepatocellular Carcinoma Cells with Downregulated ZEB2 Become Resistant to Resveratrol by Concomitant Induction of ABCG2 Expression].
Balcik-Ercin P; Cetin M; Yalim-Camci I; Uygur T; Yagci T
Mol Biol (Mosk); 2020; 54(1):87-94. PubMed ID: 32163392
[TBL] [Abstract][Full Text] [Related]
26. MYC fails to efficiently shape malignant transformation in T-cell acute lymphoblastic leukemia.
Loosveld M; Bonnet M; Gon S; Montpellier B; Quilichini B; Navarro JM; Crouzet T; Goujart MA; Chasson L; Morgado E; Picard C; Hernandez L; Fossat C; Gabert J; Michel G; Nadel B; Payet-Bornet D
Genes Chromosomes Cancer; 2014 Jan; 53(1):52-66. PubMed ID: 24249258
[TBL] [Abstract][Full Text] [Related]
27. The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.
Gamba CO; Damasceno KA; Ferreira IC; Rodrigues MA; Gomes DA; Alves MR; Rocha RM; Lima AE; Ferreira E; Cassali GD
PLoS One; 2019; 14(1):e0209497. PubMed ID: 30645591
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.
Balcik-Ercin P; Cetin M; Yalim-Camci I; Odabas G; Tokay N; Sayan AE; Yagci T
Cell Oncol (Dordr); 2018 Aug; 41(4):379-393. PubMed ID: 29516288
[TBL] [Abstract][Full Text] [Related]
29. Zinc finger E‑box binding homeobox 2 functions as an oncogene in human laryngeal squamous cell carcinoma.
Li Q; Ma L; Wu Z; Wang G; Huang Q; Shen Z; Yu R
Mol Med Rep; 2019 Jun; 19(6):4545-4552. PubMed ID: 30957184
[TBL] [Abstract][Full Text] [Related]
30. Akt and Notch pathways mediate polyhexamethylene guanidine phosphate-induced epithelial-mesenchymal transition via ZEB2.
Jeong MH; Kim HR; Park YJ; Chung KH
Toxicol Appl Pharmacol; 2019 Oct; 380():114691. PubMed ID: 31348943
[TBL] [Abstract][Full Text] [Related]
31. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling.
Goossens S; Radaelli E; Blanchet O; Durinck K; Van der Meulen J; Peirs S; Taghon T; Tremblay CS; Costa M; Farhang Ghahremani M; De Medts J; Bartunkova S; Haigh K; Schwab C; Farla N; Pieters T; Matthijssens F; Van Roy N; Best JA; Deswarte K; Bogaert P; Carmichael C; Rickard A; Suryani S; Bracken LS; Alserihi R; Canté-Barrett K; Haenebalcke L; Clappier E; Rondou P; Slowicka K; Huylebroeck D; Goldrath AW; Janzen V; McCormack MP; Lock RB; Curtis DJ; Harrison C; Berx G; Speleman F; Meijerink JP; Soulier J; Van Vlierberghe P; Haigh JJ
Nat Commun; 2015 Jan; 6():5794. PubMed ID: 25565005
[TBL] [Abstract][Full Text] [Related]
32. Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of
Wang CJ; Jia MZ; Deng LP; Li WJ; Zhang Q; Zhang TJ; Li SY; Cui L; Li ZG
Pediatr Hematol Oncol; 2022 Sep; 39(6):549-560. PubMed ID: 35139734
[TBL] [Abstract][Full Text] [Related]
33. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
35. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
Ji H; Sang M; Liu F; Ai N; Geng C
Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
[TBL] [Abstract][Full Text] [Related]
36. Molecularly distinct models of zebrafish Myc-induced B cell leukemia.
Borga C; Foster CA; Iyer S; Garcia SP; Langenau DM; Frazer JK
Leukemia; 2019 Feb; 33(2):559-562. PubMed ID: 30573774
[No Abstract] [Full Text] [Related]
37. MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2.
Zhu W; Luo X; Fu H; Liu L; Sun P; Wang Z
Pathol Res Pract; 2019 Oct; 215(10):152577. PubMed ID: 31405759
[TBL] [Abstract][Full Text] [Related]
38. The molecular basis of T cell acute lymphoblastic leukemia.
Van Vlierberghe P; Ferrando A
J Clin Invest; 2012 Oct; 122(10):3398-406. PubMed ID: 23023710
[TBL] [Abstract][Full Text] [Related]
39. Zinc Finger E-Box Binding Protein 2 (ZEB2) Suppress Apoptosis of Vascular Endothelial Cells Induced by High Glucose Through Mitogen-Activated Protein Kinases (MAPK) Pathway Activation.
Wang LJ; Wu ZH; Zheng XT; Long JY; Dong YM; Fang X
Med Sci Monit; 2017 May; 23():2590-2598. PubMed ID: 28551696
[TBL] [Abstract][Full Text] [Related]
40. Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis.
Luo W; Xu C; Ayello J; Dela Cruz F; Rosenblum JM; Lessnick SL; Cairo MS
Oncogene; 2018 Feb; 37(6):798-809. PubMed ID: 29059150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
